About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 869 record(s)
Req # A-2021-001315
Summary basis of decision and Instruction For Use (IFU) for Mirasol Pathogen Reduction Technology System model No. 106324.Organization: Health Canada
March 2023
Req # A-2021-001688
All Task Authorizations, for each COVID-19 vaccination advertisement campaign, for the time period of September 2020 to December 22, 2021.Organization: Health Canada
March 2023
Req # A-2021-002144
Records for the service agreement between the Public Health Agency of Canada (PHAC) and Service Canada, managed by Health Canada, for the toll-free lines 1-833-784-4397 and 1-844-280-5020 as well as names of employees, description of their roles, their direct contact information who relay the information to Service Canada. Records for years 2019, 2020, 2021, and 2022.Organization: Health Canada
March 2023
Req # A-2022-000144
All adverse reaction reports, excluding foreign reports, where olanzapine, as the active ingredient is listed as the suspect medication for individuals aged 65 and older between the dates of January 1, 1997 to April 27, 2021.Organization: Health Canada
March 2023
Req # A-2022-000425
All receipts for the expense referred to in Sessional Paper 8555-441-494, tabled in the House of Commons on June 8, 2022, with the following vendor, amount, date of expenditure, and file number: Joe’s Smoke Shop & Grocer, $1,152.90, March 22nd, 2022, 162853.Organization: Health Canada
March 2023
Req # A-2022-000426
All receipts for the expense referred to in Sessional Paper 8555-441-494, tabled in the House of Commons on June 8, 2022, with the following vendor, amount, date of expenditure, and file number: Clear Sky Vapes, $37.00, March 24th, 2022, 162857.Organization: Health Canada
March 2023
Req # A-2022-000690
The following submissions:GLUMETZA , GLUMETZA (SB) - METFORMIN HYDROCHLORIDE. BAUSCH HEALTH, CANADA INC. Notice of Compliance (NOC) Date: 2022/01/25. Supplements to New Drug Submission (SNDS). Reason for Update: Update the design of bottle labels Remove the package insert from all packaging. Including: All reviewer notes.Organization: Health Canada
March 2023
Req # A-2022-000802
Clinical and chemistry review report for PEMETREXED FOR INJECTION 25 MG / ML from Accord Healthcare Inc. on 2021-04-29 by Health Canada.Organization: Health Canada
March 2023
Req # A-2022-000916
The Imperial Tobacco Canada Ltd. submission in response to consultation on the proposed Regulations Amending the Tobacco Products Regulations published in the Canada Gazette Part I on June 11, 2022.Organization: Health Canada
March 2023
Req # A-2022-000992
The initial cover letter or any other document indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-10-20 for the medicinal ingredient mirabegron. The Screening Acceptance Letter from Health Canada to the generic drug manufacturer confirming completion of screening of the Abbreviated New Drug Submission (ANDS) for mirabegron which appears in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-10-20.Organization: Health Canada
March 2023